Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.56 BRL | +2.34% |
|
+0.43% | +17.24% |
14/06 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
14/06 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
- Stock Market
- Equities
- AMGN Stock
- AMGN34 Stock
- News Amgen Inc.